Tawbi, H.
48  results:
Search for persons X
?
2

Calcium-sensing receptor autoantibody-mediated hypoparathyr..:

Dadu, R ; Rodgers, T.E ; Trinh, V.A...
https://eprints.whiterose.ac.uk/160473/8/e000687.full.pdf.  , 2020
 
?
 
?
4

A randomised phase II trial of selumetinib vs selumetinib p..:

Eroglu, Z ; Tawbi, H A ; Hu, J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430716/.  , 2015
 
?
5

PD-1 and Tim-3 regulate the expansion of tumor antigen-spec..:

Fourcade, J ; Sun, Z ; Pagliano, O...
info:eu-repo/semantics/altIdentifier/doi/10.1158/0008-5472.CAN-13-2908.  , 2014
 
?
6

Role of PARP Inhibitors in Cancer Biology and Therapy:

Davar, D ; Beumer, J.H ; Hamieh, L.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421454.  , 2012
 
?
7

Inhibition of DNA repair with MGMT pseudosubstrates: phase ..:

Tawbi, H A ; Villaruz, L ; Tarhini, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171007.  , 2011
 
?
9

Short-term treatment with multi-drug regimens combining BRA..:

MG White (11742986) ; R Szczepaniak Sloane (11742989) ; RG Witt (11742992)...
https://figshare.com/articles/journal_contribution/Short-term_treatment_with_multi-drug_regimens_combining_BRAF_MEK-targeted_therapy_and_immunotherapy_results_in_durable_responses_in_Braf-mutated_melanoma/17065733.  , 2021
 
?
11

Distinct molecular and immune hallmarks of inflammatory art..:

Kim, Sang T ; Chu, Yanshuo ; Misoi, Mercy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005525/.  , 2022
 
?
 
?
 
1-15